Extended report
Decreased serum biochemical markers of muscle origin in
patients with ankylosing spondylitis
Erik J Giltaya, Dirkjan van Schaardenburgd, Louis J G Goorena, Piet J Kostensec, Ben A C Dijkmansb
a Institute of
Endocrinology, Reproduction and Metabolism, b Department of Rheumatology, c Department of Clinical Epidemiology
and Biostatistics, d University
Hospital Vrije Universiteit, Amsterdam, the Netherlands
Department of Rheumatology, Jan van Breemen
Institute, Amsterdam, the Netherlands
Correspondence to: Dr E J Giltay, Department of Endocrinology/Division of Andrology, University Hospital Vrije Universiteit, PO Box 7057, 1007 MB, Amsterdam, the Netherlands.
Accepted for publication 12 April 1999
OBJECTIVES
There is a
lack of unanimity about (increased) serum levels of creatine kinase
(CK) in patients with ankylosing spondylitis (AS), perhaps because of
the inclusion of inappropriate controls. Therefore, serum levels of
biochemical markers of muscle origin were assessed in AS patients
compared with controls.
METHODS
In a
comparative study serum levels of sarcoplasmic proteins indicating
muscle cell leakage, creatinine, and C reactive protein (CRP) were
measured. Fifty eight AS patients with a mean disease duration of 22 (SD 11) years and 58 age and sex matched controls (without back
complaints) were included.
RESULTS
Lower serum
levels in AS patients compared with controls were found for CK (mean
(SD): 46 (21) v 76 (44) IU/l; p<0.001),
aldolase (0.43 (0.36) v 0.58 (0.32) IU/l;
p=0.001), creatinine (91 (13) v 96 (11)
µmol/l; p=0.02), alanine aminotransferase (2.8 (1.5) v 4.1 (2.9) IU/l; p=0.001) and aspartate
aminotransferase (7.0 (2.7) v 8.4 (3.5)
IU/l; p=0.02). Also the lean body mass, as estimated by a formula using
height, weight, age and sex, showed lower values in patients versus
controls (56 (9) v 59 (9) kg; p=0.004), but creatinine clearance (by Cockcroft and Gault formula) was not different
(p=0.48). Partial correlation coefficients adjusted for age and sex
showed that CRP levels correlated negatively with CK and aldolase
levels in AS patients (r=
0.48, p<0.001
and r=
0.37, p=0.005, respectively).
CONCLUSION
Serum
levels of biochemical markers of muscle origin were lower in AS
patients compared with controls. Patients with active AS, as reflected
by high CRP levels, may have an increased protein degradation,
predominantly in skeletal muscle.
© 1999 by Annals of the Rheumatic Diseases
This article has been cited by other articles:
-
Marcora, S., Casanova, F., Williams, E., Jones, J., Elamanchi, R., Lemmey, A.
(2006). Preliminary evidence for cachexia in patients with well-established ankylosing spondylitis. Rheumatology (Oxford)
45: 1385-1388
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
